Litigation & Arbitration
Mar. 24, 2023
Plaintiffs’ experts not excluded from Zantac trial
GlaxoSmithKline LLC moved to exclude the testimony under Evidence Code Sections 801 and 802, which allow the court to disqualify testimony when an expert is unqualified, their conclusions are unsupported by the material they cite or their assertions are speculative.
An Alameda County judge on Thursday denied motions by GlaxoSmithKline LLC to exclude the testimony of plaintiffs’ experts in a case involving cancer diagnoses allegedly linked to the drug Zantac.
Judge Evelio M. Grillo denied six defense motions to exclude expert testimony, while granting four motions in part and one motion entirely. The defendant moved to exclude the testimony under Evidence Code Sections 801 a...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In